Markets

Geokinetics Inc. (NYSEAMEX: GOK) closed Thursday with an incline of 30.30% to a market valuation of $0.430 per share, closing higher than its opening of $0.35 per share. Volume closed at 230,556.00, bypassing its average of 209,574.00 for the day. Market capitalization closed at 8.48M. GOK remains oversold as its RSI falls to 47.53. The company’s MACD however has taken an upward turn, revealing an increased cash flow towards the company’s equity.

DO NOT BUY OR SELL GOK UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=GOK

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) closed Thursday on a positive note with an increase of 16.00% to $0.580 per share after the company announced a new publication showing adult patients with refractory chronic gout (RCG) treated bi-weekly with KRYSTEXXA® (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain and physical function. Volume followed suit and rose to 2.06M, bypassing its average of 1.52M for the day. Market capitalization for the company stands at 41.99M as well.

DO NOT BUY OR SELL SVNT UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=SVNT

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) closed with an increase of 13.27% to a market valuation of $11.35 after the company announced the promotion of Craig M. Audet to the position of Senior Vice President, Operations and Head of Global Regulatory Affairs. In his new role, Audet will serve as an executive officer of the company. Audet, 48, will oversee various operations at Arena, including investor relations and alliance management, and will continue to lead regulatory affairs. The company fell slightly during the after hours by 0.18% to a market valuation of $11.33 per share. Volume surged to 42.21M, bypassing its average of 29.25M.

DO NOT BUY OR SELL ARNA UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=ARNA

Coronado Biosciences Inc. (NASDAQ: CNDO) closed Thursday at $6.90 per share, increasing by 20.00% after the company announced that Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, will present at the 2012 JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 1:00 pm ET. Volume followed suit, rising to 705,594.00 shares, its average being 185,135.00. Market capitalization for the company stands at 128.52M as well. CNDO has a reported RSI of 65.20, indicating an undersold level for the company.

DO NOT BUY OR SELL CNDO UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=CNDO

About HotStockProfits.com

HotStockProfits.com is owned and operated by ALG Financial, a full-service financial communications and investor relations firm. HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Subscribe to the FREE e-newsletter: www.HotStockProfits.com

Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.

CONTACT:

HOTSTOCKPROFITS.COM

ADMIN@HOTSTOCKPROFITS.COM

Source: HotStockProfits.com